The Path to Selection and Implementation of Value-Based Contracts
Pricing: Free for members and $30 for non-members
Course Description
As innovative, high-cost treatment options become more available in the US health care market, there has been increasing desire among stakeholders to shift towards payment models based on treatment value and outcomes. For payers, these payment models also help share risk when therapies are approved through the expedited review pathways that offer limited evidence upon approval.
This session will review the various types of value-based arrangements with a focus on newer models and the current role of value-based arrangements among key stakeholders with examples of how best to select and utilize specific payment models.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Summarize the current landscape relative to the adoption of value-based arrangements among manufacturers, payers, and health systems.
- Identify best practices and challenges with implementing various types of value-based arrangements.
- List key considerations when determining which type of value-based arrangement to utilize in a specific situation.
- Based on case studies, describe key learnings from the implementation of value-based arrangements and what payers are seeking with future value-based arrangements.
Faculty
Chester B. Good, MD, MPH
Senior Medical Director for Value Based Pharmacy
UPMC Health Plan
Pittsburgh, PA
Jennifer S. Graff, PharmD
Senior Director, Professional Affairs
AMCP
Alexandria, VA
Robert O'Brien, RPh
Vice President, Specialty Pharmacy
Real Endpoints
Hopewell Junction, NY
Moderator
Jessica Daw, PharmD, MBA
Senior Director, Clinical Pharmacy
UPMC Health Plan
Pittsburgh, PA
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Chester Good Faculty | Disclosed no relevant financial relationships. |
Jennifer Graff Faculty | Disclosed no relevant financial relationships. |
Robert O’Brien Faculty | Disclosed no relevant financial relationships. |
Annie Schuster Reviewer | Employee/Stock Options: Cigna |
Ruby Singh Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-22-050-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: October 13, 2022 • Expiration Date: December 31, 2023
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2022. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion